Fate Therapeutics (FATE) Amortizatization of Intangibles (2012 - 2026)

Fate Therapeutics has reported Amortizatization of Intangibles for 14 years, with the latest figure at $772000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 27.72% year-over-year to $772000.0; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 55.97% YoY), and the FY2025 full-year result was $3.6 million, down 60.29% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $772000.0, down from $881000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $3.3 million in Q3 2023, with the low at -$873000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.5 million across 5 years, with a median of $1.2 million in 2022.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 696.33% — and 2025, when it slumped 68.89%.
• Fate Therapeutics' Amortizatization of Intangibles stood at $1.2 million in 2022, then jumped by 133.41% to $2.9 million in 2023, then plunged by 47.35% to $1.5 million in 2024, then tumbled by 42.42% to $881000.0 in 2025, then fell by 12.37% to $772000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $772000.0 (Q1 2026), $881000.0 (Q4 2025), and $810000.0 (Q3 2025), per Business Quant data.